Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MDN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC11A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SYT12 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SMAD5-AS1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
RPS7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SIGLEC7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYP11B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPTBN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC100653049 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TFAP2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TBC1D22A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYP3A43 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPL34 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC26A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GCK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRDM2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TP53I11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYO5A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PXDN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on